Comparison of modes of ascertainment for mosaic vs complete trisomy 21

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 4, 2009, Pages 440.e1-440.e5

  Bornstein, Eran ^a   Lenchner, Erez ^b   Donnenfeld, Alan ^d   Kapp, Sara ^a   Keeler, Sean M ^a   Divon, Michael Y ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c LENOX HILL HOSPITAL   (United States)

^d Genzyme Genetics   (United States)

Author keywords

Down syndrome; mosaic; prenatal diagnosis; trisomy 21

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; ECHOGRAPHY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HEART DISEASE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MATERNAL AGE; MOSAICISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; TRISOMY 21;

EID: 62549091438     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.01.017     Document Type: Article

References (36)

1. Center for Disease Control. Improved national prevalence estimates for 18 selected major birth defects, United States, 1999-2001. MMWR Morb Mortal Wkly Rep 54 (2006) 1301-1305
2. Dreux S., Olivier C., Dupont J.M., et al. Maternal serum screening in cases of mosaic and translocation Down syndrome. Prenat Diagn 28 (2008) 699-703
3. Antonarakis S.E. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms: Down syndrome collaborative group. N Engl J Med 324 (1991) 872-876
4. Mutton D., Alberman E., and Hook E.B. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993: National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet 33 (1996) 387-394
5. Brisset S., Aboura A., Audibert F., et al. Discordant prenatal diagnosis of trisomy 21 due to mosaic structural rearrangements of chromosome 21. Prenat Diagn 23 (2003) 461-469
6. Stoll C., Alembik Y., Dott B., and Roth M.P. Epidemiology of Down syndrome in 118,265 consecutive births. Am J Med Genet Suppl 7 (1990) 79-83
7. Gardner R.J., and Sutherland G.R. Down syndrome, other full aneuploidies and polyploidy. In: Gardner R.J., and Sutherland G.R. (Eds). Chromosome abnormalities and genetic counseling (2004), Oxford University Press, New York 249-256
8. Sicero S., Sonek J.D., Rembouskos G., and Nicholides K.H. Fetal nasal bone in screening for Down's syndrome. In: Kurjak A., and Chervenak F.A. (Eds). Textbook of perinatal medicine (2006), CRC Press, London 825-836
9. Cuckle H. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92 (2000) 97-101
10. Wenstrom K.D., Owen J., Chu D.C., and Boots L. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome. Am J Obstet Gynecol 177 (1997) 987-991
11. Spencer K., Souter V., Tul N., Snijders R., and Nicolaides K.H. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13 (1999) 231-237
12. Snijders R.J., Noble P., Sebire N., Souka A., and Nicolaides K.H. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation: Fetal Medicine Foundation first trimester screening group. Lancet 352 (1998) 343-346
13. Wapner R., Thom E., Simpson J.L., et al. First trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group: first-trimester screening for trisomies 21 and 18. N Engl J Med 349 (2003) 1405-1413
14. Wald N.J., Watt H.C., and Hackshaw A.K. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341 (1999) 461-467
15. Platt L.D., Greene N., Johnson A., et al., First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol 104 (2004) 661-666
16. Malone F.D., Canick J.A., Ball R.H., et al., First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
17. Cuckle H.S., Malone F.D., Wright D., et al. Contingent screening for Down syndrome-results from the FaSTER trial. Prenat Diagn 28 (2008) 89-94
18. Cicero S., Bindra R., Rembouskos G., Spencer K., and Nicolaides K.H. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 23 (2003) 306-310
19. Nicolaides K.H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 191 (2004) 45-67
20. Borrell A., Gonce A., Martinez J.M., et al. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn 25 (2005) 901-905
21. Vintzileos A.M., and Egan J.F.X. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 172 (1995) 837-844
22. Nyberg D.A., Luthy D.A., Resta R.G., Nyberg B.C., and Williams M.A. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 12 (1998) 8-14
23. Winter T.C., Uhrich S.B., Souter V.L., and Nyberg D.A. The "genetic sonogram": comparison of the index scoring system with the age-adjusted US risk assessment. Radiology 215 (2000) 775-782
24. DeVore G.R. The genetic sonogram: its use in the detection of chromosomal abnormalities in fetuses of women of advanced maternal age. Prenat Diagn 21 (2001) 40-45
25. Nyberg D.A., Souter V.L., El-Bastawissi A., Young S., Luthhardt F., and Luthy D.A. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 20 (2001) 1053-1063
26. Resta R.G. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: implications for prenatal screening and genetic counseling. Am J Med Genet 133 (2005) 31-36
27. Hsu L.Y., Kaffe S., Jenkins E.C., et al. Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies. Prenat Diagn 12 (1992) 555-573
28. Hsu L.Y., and Benn P.A. Revised guidelines for the diagnosis of mosaicism in amniocytes. Prenat Diagn 19 (1999) 1081-1082
29. Kohn G., Taysi K., Atkins T.E., and Mellman W.J. Mosaic mongolism, I: clinical correlations. J Pediatr 76 (1970) 874-879
30. Yokoyama Y., Narahara K., Kamada M., Tsuji K., and Seino Y. Tissue-specific mosaicism for trisomy 21 and congenital heart disease. J Pediatr 121 (1992) 80-82
31. Ringman J.M., Rao P.N., Lu P.H., and Cederbaum S. Mosaicism for trisomy 21 in a patient with young-onset dementia: a case report and brief literature review. Arch Neurol 65 (2008) 412-415
32. Devlin L., and Morrison P.J. Mosaic Down's syndrome prevalence in a complete population study. Arch Dis Child 89 (2004) 1177-1178
33. Simon J.H., Tebbi C.K., Freeman A.I., Brecher M.L., Green D.M., and Sandberg A.A. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome. Cancer 60 (1987) 2515-2520
34. Brodeur G.M., Dahl G.V., Williams D.L., Tipton R.E., and Kalwinsky D.K. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 55 (1980) 691-693
35. Wallerstein R., Yu M.T., Neu R.L., et al. Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype-phenotype correlations. Prenat Diagn 20 (2000) 103-122
36. Hahnemann J.M., and Vejerslev L.O. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)-diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centers contributing to EUCROMIC 1986-1992. Prenat Diagn 17 (1997) 801-820